Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
BACKGROUND:Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with a...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2728512?pdf=render |
_version_ | 1818111473713414144 |
---|---|
author | Sylvie Tordjman George M Anderson Michel Botbol Sylvie Brailly-Tabard Fernando Perez-Diaz Rozenn Graignic Michèle Carlier Gérard Schmit Anne-Catherine Rolland Olivier Bonnot Séverine Trabado Pierre Roubertoux Guillaume Bronsard |
author_facet | Sylvie Tordjman George M Anderson Michel Botbol Sylvie Brailly-Tabard Fernando Perez-Diaz Rozenn Graignic Michèle Carlier Gérard Schmit Anne-Catherine Rolland Olivier Bonnot Séverine Trabado Pierre Roubertoux Guillaume Bronsard |
author_sort | Sylvie Tordjman |
collection | DOAJ |
description | BACKGROUND:Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with autism. METHODOLOGY/PRINCIPAL FINDINGS:The study was conducted on 73 children and adolescents with autism and 115 normal individuals matched for age, sex and pubertal stage. Behavioral pain reactivity of individuals with autism was assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and child psychiatrist during blood drawing), and compared to controls during venepuncture. Plasma beta-endorphin concentrations were measured by radioimmunoassay. A high proportion of individuals with autism displayed absent or reduced behavioral pain reactivity at home (68.6%), at day-care (34.2%) and during venepuncture (55.6%). Despite their high rate of absent behavioral pain reactivity during venepuncture (41.3 vs. 8.7% of controls, P<0.0001), individuals with autism displayed a significantly increased heart rate in response to venepuncture (P<0.05). Moreover, this response (Delta heart rate) was significantly greater than for controls (mean+/-SEM; 6.4+/-2.5 vs. 1.3+/-0.8 beats/min, P<0.05). Plasma beta-endorphin levels were higher in the autistic group (P<0.001) and were positively associated with autism severity (P<0.001) and heart rate before or after venepuncture (P<0.05), but not with behavioral pain reactivity. CONCLUSIONS/SIGNIFICANCE:The greater heart rate response to venepuncture and the elevated plasma beta-endorphin found in individuals with autism reflect enhanced physiological and biological stress responses that are dissociated from observable emotional and behavioral reactions. The results suggest strongly that prior reports of reduced pain sensitivity in autism are related to a different mode of pain expression rather than to an insensitivity or endogenous analgesia, and do not support opioid theories of autism. Clinical care practice and hypotheses regarding underlying mechanisms need to assume that children with autism are sensitive to pain. |
first_indexed | 2024-12-11T03:03:36Z |
format | Article |
id | doaj.art-c280f332cfea4feeb2c64aec6f7c29ec |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-11T03:03:36Z |
publishDate | 2009-08-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-c280f332cfea4feeb2c64aec6f7c29ec2022-12-22T01:22:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-08-0148e528910.1371/journal.pone.0005289Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.Sylvie TordjmanGeorge M AndersonMichel BotbolSylvie Brailly-TabardFernando Perez-DiazRozenn GraignicMichèle CarlierGérard SchmitAnne-Catherine RollandOlivier BonnotSéverine TrabadoPierre RoubertouxGuillaume BronsardBACKGROUND:Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with autism. METHODOLOGY/PRINCIPAL FINDINGS:The study was conducted on 73 children and adolescents with autism and 115 normal individuals matched for age, sex and pubertal stage. Behavioral pain reactivity of individuals with autism was assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and child psychiatrist during blood drawing), and compared to controls during venepuncture. Plasma beta-endorphin concentrations were measured by radioimmunoassay. A high proportion of individuals with autism displayed absent or reduced behavioral pain reactivity at home (68.6%), at day-care (34.2%) and during venepuncture (55.6%). Despite their high rate of absent behavioral pain reactivity during venepuncture (41.3 vs. 8.7% of controls, P<0.0001), individuals with autism displayed a significantly increased heart rate in response to venepuncture (P<0.05). Moreover, this response (Delta heart rate) was significantly greater than for controls (mean+/-SEM; 6.4+/-2.5 vs. 1.3+/-0.8 beats/min, P<0.05). Plasma beta-endorphin levels were higher in the autistic group (P<0.001) and were positively associated with autism severity (P<0.001) and heart rate before or after venepuncture (P<0.05), but not with behavioral pain reactivity. CONCLUSIONS/SIGNIFICANCE:The greater heart rate response to venepuncture and the elevated plasma beta-endorphin found in individuals with autism reflect enhanced physiological and biological stress responses that are dissociated from observable emotional and behavioral reactions. The results suggest strongly that prior reports of reduced pain sensitivity in autism are related to a different mode of pain expression rather than to an insensitivity or endogenous analgesia, and do not support opioid theories of autism. Clinical care practice and hypotheses regarding underlying mechanisms need to assume that children with autism are sensitive to pain.http://europepmc.org/articles/PMC2728512?pdf=render |
spellingShingle | Sylvie Tordjman George M Anderson Michel Botbol Sylvie Brailly-Tabard Fernando Perez-Diaz Rozenn Graignic Michèle Carlier Gérard Schmit Anne-Catherine Rolland Olivier Bonnot Séverine Trabado Pierre Roubertoux Guillaume Bronsard Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder. PLoS ONE |
title | Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder. |
title_full | Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder. |
title_fullStr | Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder. |
title_full_unstemmed | Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder. |
title_short | Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder. |
title_sort | pain reactivity and plasma beta endorphin in children and adolescents with autistic disorder |
url | http://europepmc.org/articles/PMC2728512?pdf=render |
work_keys_str_mv | AT sylvietordjman painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT georgemanderson painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT michelbotbol painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT sylviebraillytabard painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT fernandoperezdiaz painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT rozenngraignic painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT michelecarlier painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT gerardschmit painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT annecatherinerolland painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT olivierbonnot painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT severinetrabado painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT pierreroubertoux painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder AT guillaumebronsard painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder |